The health care landscape is undergoing a significant transformation, and at the forefront of this change is the rise of consumer wearable platforms. These devices, once seen as mere fitness trackers, are now poised to become the new gatekeepers of our health.
The Rise of the Wearable Gatekeeper
In a fascinating development, companies like WHOOP, Oura, and others are no longer content with being just fitness trackers. They are actively positioning themselves as the routing layer for clinical care. This means that these wearables, through their continuous monitoring of physiological data, are now influencing the very first conversation about our health changes.
The implications of this are profound. These companies, by owning the initial dialogue about our health, can shape our decisions regarding specialists, treatments, and even the care programs we enroll in. It's a powerful position to be in, and one that raises important questions about trust, policy, and regulation.
A New Ecosystem, A New Power Dynamic
The wearable category is evolving into a powerful ecosystem. With companies like Apple, Samsung, and Alphabet's Verily actively engaging with CMS's Health Tech Ecosystem Pledge, we're witnessing a convergence of consumer technology and clinical care. This shift is not without its challenges and opportunities.
On the one hand, the current health care system is in dire need of an overhaul. Doctors are overburdened, and patients often face barriers to proactive care. Wearables and their apps can potentially bridge this gap, providing continuous monitoring and timely interventions. However, we must also consider the potential downsides.
A Cautionary Tale
As we place our trust in these wearables, we must be cautious. The culture of consumer technology is vastly different from that of healthcare. Wearable companies have built their business models on user attention, subscription revenue, and the monetization of user data. While this may be beneficial in certain contexts, it raises concerns when applied to clinical care.
Imagine a scenario where the optimization logic of a wearable platform, designed to route user attention, intersects with clinical judgment. The potential for misuse or misinterpretation is real. Additionally, the wall between a company's knowledge of a user as a customer and their actions as a clinical intermediary is entirely dependent on self-regulation. This is a delicate balance, and one that the healthcare system is not yet prepared for.
A Call for Scrutiny and Preparation
The policy and regulatory frameworks that govern patient trust were not designed for this configuration. With companies owning the monitoring, interpretation, and routing of clinical care, we must ask: Are these companies subject to the same antitrust scrutiny as physicians? How can we ensure that patient data is protected and used ethically?
As we navigate this new health care landscape, it's crucial to approach these developments with a critical eye. While the potential benefits are enticing, we must not lose sight of the potential pitfalls. The future of healthcare is upon us, and it's time to ensure that we're prepared for it.
